Page last updated: 2024-08-22

olsalazine and azathioprine

olsalazine has been researched along with azathioprine in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (16.67)18.2507
2000's3 (50.00)29.6817
2010's2 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Cosnes, J; Elefant, E; Gendre, JP; Marteau, P; Modigliani, R; Rambaud, JC; Tennenbaum, R1
Archavlis, E; Christidou, A; Karagiannidis, A; Mantzaris, GJ; Petraki, K; Sfakianakis, M; Triadaphyllou, G1
Holland, S1
Boulieu, R; Lachaux, A; Le Gall, C; Nguyen, TM1

Reviews

1 review(s) available for olsalazine and azathioprine

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Trials

1 trial(s) available for olsalazine and azathioprine

ArticleYear
A prospective randomized observer-blind 2-year trial of azathioprine monotherapy versus azathioprine and olsalazine for the maintenance of remission of steroid-dependent ulcerative colitis.
    The American journal of gastroenterology, 2004, Volume: 99, Issue:6

    Topics: Adult; Aminosalicylic Acids; Analysis of Variance; Azathioprine; Colitis, Ulcerative; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Middle Aged; Prospective Studies; Remission Induction; Risk Assessment; Severity of Illness Index; Single-Blind Method; Statistics, Nonparametric; Steroids; Treatment Outcome

2004

Other Studies

4 other study(ies) available for olsalazine and azathioprine

ArticleYear
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
    Current drug discovery technologies, 2004, Volume: 1, Issue:4

    Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration

2004
[Pregnancy outcome in inflammatory bowel diseases].
    Gastroenterologie clinique et biologique, 1999, Volume: 23, Issue:5

    Topics: Aminosalicylic Acids; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Crohn Disease; Female; Humans; Inflammatory Bowel Diseases; Mesalamine; Prednisone; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Prognosis; Surveys and Questionnaires

1999
When less is not more but at least equivalent.
    Inflammatory bowel diseases, 2004, Volume: 10, Issue:6

    Topics: Aminosalicylic Acids; Azathioprine; Clinical Trials as Topic; Colitis, Ulcerative; Drug Therapy, Combination; Gastrointestinal Agents; Humans; Immunosuppressive Agents

2004
High thiopurine metabolite concentrations associated with lymphopenia in inflammatory bowel disease (IBD) pediatric patients receiving aminosalicylates combined with azathioprine.
    International journal of clinical pharmacology and therapeutics, 2010, Volume: 48, Issue:4

    Topics: Adolescent; Aminosalicylic Acids; Azathioprine; Biotransformation; Child; Child, Preschool; Drug Therapy, Combination; Erythrocytes; Female; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Lymphopenia; Male; Mesalamine; Purines; Salicylates; Sulfasalazine

2010